Trecator Generic Name & Formulations
Legal Class
General Description
How Supplied
Manufacturer
Generic Availability
NO
Mechanism of Action
Trecator Indications
Indications
Trecator Dosage and Administration
Adult
Children
Trecator Contraindications
Contraindications
Trecator Boxed Warnings
Not Applicable
Trecator Warnings/Precautions
Warnings/Precautions
Confirm presence of susceptible bacterial infection before initiating therapy. Re-titrate when switching from Trecator SC sugar-coated tabs. Give with pyridoxine. Discontinue if severe cutaneous adverse reactions develop; treat appropriately. Diabetes. Do baseline and periodic blood glucose levels, eye exams (including ophthalmoscopy). Monitor thyroid function. Obtain SGOT and SGPT before and monthly; suspend if levels increase. Pregnancy: not recommended. Nursing mothers.
Trecator Pharmacokinetics
Absorption
Time to reach mean (SD) maximum plasma concentration after administration: 1.02 (0.55) hours. Maximum mean (SD) plasma concentration: 2.16 (0.61).
Distribution
Rapidly and widely distributed into body tissues and fluids. Plasma protein bound: ~30%. Mean (SD) apparent oral volume of distribution: 93.5 (19.2) L.
Elimination
Mean (SD) Half-life: 1.92 (0.27) hours.
Trecator Interactions
Interactions
Trecator Adverse Reactions
Adverse Reactions
GI upset, abdominal pain, excessive salivation, metallic taste, stomatitis, anorexia, liver dysfunction, psychosis, drowsiness, dizziness, restlessness, headache, postural hypotension, hypoglycemia, gynecomastia, impotence, acne; rarely; peripheral/optic neuritis, visual disturbances, pellagra, thrombocytopenia, severe cutaneous adverse reactions (eg, SJS, TEN, DRESS, AGEP).
Trecator Clinical Trials
See Literature
Trecator Note
Notes
Trecator Patient Counseling
See Literature